Huntsworth plc (LON:HNT) insider Neil Jones purchased 2,420 shares of the firm’s stock in a transaction dated Monday, November 12th. The shares were bought at an average cost of GBX 112 ($1.46) per share, with a total value of £2,710.40 ($3,541.62).

Shares of HNT stock traded up GBX 4 ($0.05) during mid-day trading on Monday, reaching GBX 114.50 ($1.50). 72,058 shares of the company were exchanged, compared to its average volume of 1,010,000. Huntsworth plc has a fifty-two week low of GBX 40 ($0.52) and a fifty-two week high of GBX 95 ($1.24).

A number of analysts have recently weighed in on HNT shares. Peel Hunt downgraded shares of Huntsworth to an “add” rating and raised their price target for the stock from GBX 115 ($1.50) to GBX 140 ($1.83) in a research report on Wednesday, July 18th. Numis Securities reissued a “buy” rating on shares of Huntsworth in a research report on Friday, September 28th. Finally, Berenberg Bank raised their price target on shares of Huntsworth from GBX 135 ($1.76) to GBX 150 ($1.96) and gave the stock a “buy” rating in a research report on Wednesday, August 15th.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at

About Huntsworth

Huntsworth plc operates as a healthcare communications and public relations company in the United States, United Kingdom, rest of Europe, Asia, and the Middle East and Africa. It operates through four divisions: Huntsworth Health, Red Consultancy, Grayling, and Citigate Dewe Rogerson (CDR). The Huntsworth Health division offers an integrated suite of communications services for the science, health, and wellbeing industries.

Featured Story: Swap

Receive News & Ratings for Huntsworth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsworth and related companies with's FREE daily email newsletter.